Since 1995, WHO has ensured a consistent approach to national, regional and global TB surveillance by providing standardized definitions, forms and registers for the recording and reporting of individual-level and aggregated data about people diagnosed with and treated for TB, which are used worldwi...de. This standardization has facilitated the regular reporting of TB data to WHO from 215 countries and areas in annual rounds of global TB data collection, with findings published in an annual WHO global TB report since 1997 and data made publicly available via the online WHO global TB database.
more
Von den nachstehend aufgeführten Ärztinnen und Ärzten wird das "Beratungsnetzwerk Tuberkulose" des Bundesverbandes der Ärztinnen und Ärzte des Öffentlichen Gesundheitsdienstes (BVÖGD) unterhalten, das sich seit dem Jahr 2000 in der Praxis bewährt hat. Es wird – in Ergänzung vorhandener ü...berregionaler Beratungsangebote (DZK, NRZ, RKI) – fachlicher Rat zur Tuberkulose (Prävention, Früherkennung, empfohlene Maßnahmen) auf schriftlichem Wege, per Telefon oder über E-Mail angeboten. Adressaten sind vor allem Mitarbeiterinnen und Mitarbeiter des ÖGD, bei dringlichem Beratungsbedarf auch ärztliche Kolleginnen und Kollegen in Gesundheitseinrichtungen unterschiedlicher Träger oder in eigener Niederlassung.
more
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...ities in these diseases is essential for taking strategic, evidence-informed action to realize our shared vision of ending the epidemics of HIV, TB and malaria.
This report presents the first comprehensive analysis of the magnitude and patterns of socioeconomic, demographic and geographic inequalities in disease burden and access to services for prevention and treatment.
The results confirm there have been improvements in service coverage and decreased disease burden at the national level over the past decade. But they also reveal an uncomfortable reality: unfair inequalities between population subgroups within countries are widespread and have remained largely unchanged over the past decade. For some disease indicators, inequalities are even worsening.
Moreover, the report points to the persistent lack of available data to fully understand inequality patterns in HIV, TB and malaria. Collecting data to improve the monitoring of inequalities in these diseases is vital to develop targeted responses for impact.
There are, encouragingly, isolated successes in reducing inequities. Change is possible when deliberate action is taken to reach disadvantaged populations.
more
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...accine to improve TB
treatment outcomes
more
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...ountry and WHO-reported TB burden, (ii) the possible impact of screening thresholds on sensitivity, and (iii) the value of WHO-estimated TB burden to improve the prediction accuracy of screening yield.
more
Eur Respir J 2017; 50: 1700918
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...ркулеза, в том числе новым и применяющимся по новым показаниям.
more
treat TB
Description of Research Outputs, 2009 - 2014